Blog

Recently, the National Medical Products Administration (NMPA) conducted regular inspections on Medicilon Biopharmaceutical’s implementation of the “GLP”. The inspection results showed that Medicilon is in the organization and management of drug safety evaluation. And results, whether the personnel, equipment and experimental materials, standard operating procedures and test operation meet the GLP requirements. The inspection resultsRead more

In September 2017, the FDA inspectors, Dr. Mark Seaton, Dr. Zhou Chen and Ms. Betsy Galliher conducted a comprehensive and detailed examination on the organization and management, personnel, SOP, experimental facilities, archives, experimental implementation, QA system, computerized system of Medicilon.  During the inspection, the FDA inspectors picked a number of research topics to conduct aRead more

On Dec 13, all the VPs who responsible for drug safety evaluation from Shanghai gathered together at Pudong to attend the annual GLP meeting held by Medicion Preclinical Research (Shanghai) LLC.  During the meeting, every VP shared their own thoughts and discussed the future trends of drug safety evaluations and the policies of biotechnology industryRead more